Current indication for hematopoietic cell transplantation in adults
Open Access
- 1 October 2017
- journal article
- review article
- Published by Wolters Kluwer Health in Hematology/Oncology and Stem Cell Therapy
- Vol. 10 (4) , 178-183
Abstract
With advances in transplantation technology and supportive care practices, hematopoietic cell transplantation (HCT) has become relatively safer and the applicability of HCT continues to expand. However, appropriate selection of transplant candidates remains challenging. Identifying adult patients who may benefit from HCT involves consideration of patient and disease factors, including overall health, prior therapies, age, comorbidity, and disease/disease risk. The eligibility of transplants should be decided on a case by case basis, based upon a riskbenefit assessment. The advent of the tools for assessing patient factors such as HCT- specific comorbidity index and disease factors such as disease risk index serve as assets for the decision-making process. Besides those approaches, psychosocial assessment to know the candidates’ personalities and related issues are crucial in order to maximize patients’ participation in their own care and to lay the foundation for a successful return to their personal and professional life after HCT.Keywords
This publication has 13 references indexed in Scilit:
- Pre-existing invasive fungal infection is not a contraindication for allogeneic HSCT for patients with hematologic malignancies: a CIBMTR studyBone Marrow Transplantation, 2016
- Transplantation for myelodysplastic syndromes: who, when, and which conditioning regimensHematology-American Society Hematology Education Program, 2016
- Indications for Autologous and Allogeneic Hematopoietic Cell Transplantation: Guidelines from the American Society for Blood and Marrow TransplantationTransplantation and Cellular Therapy, 2015
- Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015Bone Marrow Transplantation, 2015
- Allogeneic hematopoietic cell transplantation for acute myeloid leukemia in older adultsHematology-American Society Hematology Education Program, 2014
- Geriatric assessment to predict survival in older allogeneic hematopoietic cell transplantation recipientsHaematologica, 2014
- No increased mortality from donor or recipient hepatitis B- and/or hepatitis C-positive serostatus after related-donor allogeneic hematopoietic cell transplantationTransplant Infectious Disease, 2012
- Effect of Age on Outcome of Reduced-Intensity Hematopoietic Cell Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission or With Myelodysplastic SyndromeJournal of Clinical Oncology, 2010
- Allogeneic Hematopoietic Stem-Cell Transplantation for Patients 50 Years or Older With Myelodysplastic Syndromes or Secondary Acute Myeloid LeukemiaJournal of Clinical Oncology, 2010
- Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning: influence of pretransplantation comorbiditiesBlood, 2004